MedTrace Logo

Safety and Tolerability of Lactoferrin in Very Low Birth Weight Infants

NCT02731092 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2016-04-19

No results posted yet for this study

Summary

To evaluate the safety and tolerability of three different lactoferrin doses in preterm infants

Conditions

  • Very Low Birth Weight Infants

Interventions

DIETARY_SUPPLEMENT

Lactoferrin

Bovine Lactoferrin 100 mg/ml dissolved in sterile water

Sponsors & Collaborators

  • The Gerber Foundation

    collaborator OTHER

  • University of Virginia

    lead OTHER

Principal Investigators

  • David A Kaufman, MD · University of Virginia School of Medicine

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Max Age
14 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-30
Primary Completion
2016-12-31
Completion
2017-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02731092 on ClinicalTrials.gov